Effects of the phosphodiestrase-4 inhibitor rolipram on lung resistance and inflammatory reaction in experimental asthma

Journal of Physiology and Pharmacology

Volumn 57, Issue SUPPL. 4, 2006, Pages 229-239

  Nejman Gryz, P ^a   Grubek Jaworska, H ^a   Glapinski J ^b   Hoser, G ^c   Chazan, R ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b INSTITUTE OF BIOCYBERNETICS AND BIOMEDICAL ENGINEERING   (Poland)

^c MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

Author keywords

Dexamethasone; Experimental asthma; Guinea pigs; Phosphodiesterase 4; Rolipram

Indexed keywords

CLEMASTINE; DEXAMETHASONE; DEXAVEN; HISTAMINE; OVALBUMIN; PHOSPHODIESTERASE IV INHIBITOR; ROLIPRAM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG EFFECT; EOSINOPHIL; GUINEA PIG; INFLAMMATION; INFLAMMATORY CELL; LUNG LAVAGE; LUNG RESISTANCE; MACROPHAGE; MALE; NEUTROPHIL; NONHUMAN;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; DEXAMETHASONE; GUINEA PIGS; HISTAMINE; INFLAMMATION; LEUKOCYTE COUNT; LUNG; MALE; OVALBUMIN; PHOSPHODIESTERASE 4 INHIBITORS; PHOSPHODIESTERASE INHIBITORS; ROLIPRAM;

EID: 33750388119     PISSN: 08675910     EISSN: 08675910     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Peachell PT, Macglashan DW, Lichtenstein LM, Schleimer RP. Regulation of human basophil and lung mast cell function by cyclic adenosine monophosphate. J Immunol 1988; 140: 571-579.
2. Nielson CP, Vestal RE. Effects of adenosine on polymorphonuclear leucocyte function, cyclic 3′:5. adenosine monophosphate and intracellular calcium. Br J Pharmacol 1989; 97: 882-888.
3. Lingk DS, Chan MA, Gelfand EW. Increased cyclic adenosine monophosphate levels block progression but not initiation of human T-cell proliferation. J Immunol 1987; 145: 449-455.
4. Torphy TJ. Phosphodiesterase inhibitors. In Asthma, Barnes PJ, Grunstein MM, Leff AR, Woolcock AJ (eds). Philadelphia, Lippincott-Raven Publishers, 1997, pp. 1755-1773.
5. Schramm CM, Grunstein MM. Assessment of signal transduction mechanisms regulating airway smooth muscle contractility. Am J Physiol 1992; 262: 119-139.
6. Welsh MJ. Electrolyte transport by airway epithelia. Physiol Rev 1987; 67: 1143-1184.
7. Tamaoki J, Kondo M, Takizawa T. Effect of cAMP on ciliary function in rabbit tracheal epithelial cells. J Appl Physiol 1989; 66: 1035-1039.
8. Pober JS, Slowik MR, De Luca LG, Ritchie AJ. Elevated cAMP inhibits endothelial cell synthesis and expression of TNF- induced endothelial leukocyte adhesion molecule-1, and vascular cell adhesion molecule-1, but not intercellular adhesion molecule-1. J Immunol 1993; 150: 5114-5123.
9. Torphy TJ, Undem BJ, Cieslinski LB, Luttmann MA, Reeves ML, Hay DWP. Identification, characterization and functional role of phosphodiesterase isozymes in human airway smooth muscle. J Pharmacol Exp Ther 1993; 265: 1213-1223.
10. Torphy TJ. Phosphodiestherase isozymes. Am J Respir Crit Care Med 1998; 157: 351-370.
11. Persson CGA. Owerview of effects of theophylline. J Allergy Clin Immunol 1986; 78: 780-787.
12. Vignola AM. PDE4 inhibitors in COPD-a more selective approach to treatment. Resp Med 2004; 98: 495-503.
13. Oger S et al. Anti-inflammatory and utero-relaxant effects in human myometrium of new generation phosphodiesterase 4 inhibitors. Biol Reprod 2004; 70: 458-464.
14. Silver PJ, Hamel LT, Perrone MH, Bentley RG, Bushover CR, Evans DB. Differential pharmacologic sensitivity of cyclic nucleotide phosphodiesterase isozymes isolated from cardiac muscle, arterial and airway smooth muscle. Eur J Pharmacol 1988; 150: 85-94.
15. Howell RE, Sickels BD, Woeppel SL. Pulmonary antiallergic and bronchodilator effects of isozyme-selective phosphodiesterase inhibitors in guinea pigs. J Pharmacol Exp Ther 1993; 264: 609-615.
16. Underwood DC, Kotzer CJ, Bochnowicz S. Comparison of phosphodisterase III, IV and dual III/IV inhibitors on bronchospasm and pulmonary eosinophil influx in guinea pig. J Pharmacol Exp Ther 1994; 270: 250-259.
17. Iijima H, Ishii M, Yamauchi K et al. Bronchoalveolar lavage and histologic characterization of late asthmatic response in guinea pigs. Am Rev Respir Dis 1987; 136: 922-929.
18. Wood-Baker R, Holgate ST. The comparative action and adverse effect profile of single doses of H1- receptor antihistamines in the airway and skin of subjects with asthma. J Allergy Clin Immunol 1993; 91: 1005-1014.
19. Reaburn D, Underwood SL, Lewis SA. Anti-inflammatory and bronchodilator properties of RP 73401, a novel and selective phosphodiesterase type IV inhibitor. Br J Pharmacol 1994; 113: 1423-1431.
20. Underwood DC, Osborn RR, Novak LB et al. Inhibition of antigen - induced bronchoconstriction and eosinophil infiltration in the guinea pig by the cyclic AMP-specific phosphodiesterase inhibitor, rolipram. J Pharmacol Exp Ther 1993; 266: 306-313.
21. 2 receptor dysfunction. Am J Respir Crit Care Med 2001; 163: 1484-1492.
22. Kuss H. Hoefgen N, Johanssen S, Kronbach T, Rundfeldt C. In vivo efficacy in airway disease models of N-(3,5-dichloropyrid-4-yl)-(1-(4-fluorobenzyl)-5- hydroxy-indole-3-yl)-glyoxylic acid amide (AWD12-281), a selective phosphodiesterase 4 inhibitor for inhaled administration. J Pharmacol Exp Ther 2003; 307: 373-385.
23. Toward TJ, Broadley KJ. Early and late bronchoconstriction, airway hyperreactivity, leucocyte influx and lung. Clin Exp Allergy 2004; 34: 91-102.
24. Vargas MH, Montano ML, Vanda B, Segura P, Selman M. Pharmacological characterization of mediators and vagal influence in the acute allergic bronchoconstriction in guinea pigs. Naunyn Schmiedebergs Arch Pharmacol 1990; 342: 278-83.
25. Grubek-Jaworska H, Rybus L, Droszcz P, Droszcz W, Wałajtys-Rode E. Wpływ krótkotrwałego podawania deksametazonu na wybrane parametry popłuczyn oskrzelowo-pecherzykowych w przebiegu reakcji opóźnionej nadwrażliwości w płucach świnek morskich. Pneumonol Alergol Pol 1994; 62 Suppl 4: 24-31.
26. Akdis CA, Blaser K. Histamine in the immune regulation and inflammation. J Allergy Clin Immunol 2003; 112: 15-22.
27. Layseca-Espinosa E, Baranda L, Alvarado-Sanchez B, Portales-Perez D, Portillo-Salazar H, Gonzalez-Amaro R. Rolipram inhibits polarization and migration of human T lymphocytes. J Invest Dermatol 2003; 121: 81-87.
28. Hansen I, Klimek L, Mosges R, Hormann K. Mediators of inflammation in the early and the late phase og allergic rhinitis. Curr Opin Allergy Clin Immunol 2004; 4: 159-163.
29. Gallico L, Oggioni N, Dalla Rosa C, Ceserani R, Tognella S. Effects of moguisteine, a peripheral nonnarcotic antitussive agent, on airway inflammation in guinea-pigs in vivo. Eur Respir J 1996; 9: 478-485.
30. Gosset P, Jeannin P, Lassalle P, Joseph M, Tonnel AB. The role of endothelial cells in asthma. In Asthma, Barnes PJ, Grunstein MM, Leff AR, Woolcock AJ (eds). Philadelphia, Lippincott-Raven Publishers, 1997, pp. 507-522.
31. Broide DH, Humber D, Sullivan S, Sriramarao P. Inhibition of eosinophil rolling and recruitment in P-selectin and intracellular adhesion molecule-1 deficient mice. Blood 1998; 91: 2847-2856.
32. Eum SY, Maghni K, Hamid Q et al. Inhibition of allergic airways inflammation and airway hyperresponsiveness in mice by dexamethasone: role of eosinophils, IL-5, eotaxin, and IL-13. J Allergy Clin Immunol 2003; 111: 1049-1061.
33. Shen H, O'Byrne PM, Ellis R, Wattie J, Tang C, Inman MD. The effect of intranasal budesonide on allergen-induced production of interleukin-5 and eotaxin, blood, and bone marrow eosinophilia, and eosinphil progenitor expansion in sensitized mice. Am J Resp Crit Care Med 2002; 166: 146-153.
34. Humbles AA, Conroy DM, Marleau S et al. Kinetics of eotaxin generation and its relationship to eosinophil accumulation in allergic airways disease: analysis in a guinea pig model in vivo. J Exp Mec 1997; 186: 601-612.
35. Berkman N, Ohnona S, Chung FK, Breuer R. Eotaxin-3 but not eotaxin gene expression is upregulated in asthmatic 24 hours after allergen challenge. Am J Respir Cell Mol Biol 2001; 24: 682-687.
36. Schroeder JT, MacGlashan DWJr, MacDonald SM, Kagey-Sobotka A, Lichtenstein LM. Regulation of IgE-dependent IL-4 generation by human basophils treated with glucocorticoids. J Immunol 1997; 158: 5448-5454.
37. Gundel RH, Kinkade P, Torcellini CA et al. Antigen-induced mediator release in primates. Am Rev Respir Dis 1991; 144: 76-82.
38. Shichijo M, Inagaki M, Kimata M, Serizawa I, Saito H, Nagai H. Role of cyclic 3′,5′ -adenosine monophosphate in the regulation of chemical mediator release and cytokine production from cultured human mast cells. J Allergy Clin Immunol 1999; 103: 421-428.
39. Weston MC, Anderson N, Peachell PT. Effects of phosphodiesterase inhibitors on human lung mast cell and basophil function. Br J Pharmacol 1997; 121: 287-295.